TIA’s investment in nucleic acid production

TIA is pleased to announce our latest investment in a pilot facility at BASE, UQ to produce high-quality nucleic-acid (mRNA, DNA) to support academic, translational and industrial research.

BASE harnesses the collective UQ expertise of the leading RNA research by Associate Professor Timothy Mercer, the biomanufacturing powerhouse National Biologics Facility led by Professor Trent Munro, and the RNA and DNA production expertise of the Protein Expression Facility, led by Professor Linda Lua.

Professor Trent Munro, Professor Linda Lua and Associate Professor Timothy Mercer © UQ.

TIA CEO Dr Stuart Newman said that this support would enable the facility to produce high-quality, high-purity nucleic acids – RNA and DNA – to support the work of nucleic acid researchers across the country.

“This investment complements recent investments in later-stage, large-scale mRNA manufacturing, as well as TIA’s own ongoing investment in biologics production to support R&D,” Dr Newman said.

Read the full article by the University of Queensland.